Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2022 –2029 | |
|
|
USD 0.31 Billion |
| USD 1.11 Billion | |
| % | |
|
Global Optogenetics Market, By Light Equipment Type (Laser, and Light-emitting Diode (LED)), Actuator (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin), Sensor (Calcium Aequorin, Cameleon, and Other, Chloride (Clomeleon), Membrane-gated (Mermaid), pH Sensors, Genetically Modified Calcium Indicators, Neurotransmitter Release, Voltage-sensitive Fluorescent Proteins), Application (Neuroscience, Behavioral Tracking, Retinal Disease Treatment, and Others) – Industry Trends and Forecast to 2030.
According to the Parkinson's Foundation 2020, approximately 1.2 million people in the United States may have Parkinson's disease by 2030. Furthermore, according to the Alzheimer Society of Canada 2021, over 500,000 Canadians were living with dementia. This number is expected to rise to 912,000 by 2030. According to the Public Health Agency of Canada News release 2019, nine seniors are diagnosed with dementia in Canada every hour. According to the National Institutes of Health, the estimated investment for neurosciences in 202 is USD 10,353 million in May 2020, a significant increase from the USD 10,353 million figures in 2020. The growing investment in neuroscience is expected to increase the demand for optogenetics, a novel method of identifying neurological disorders. This factor is expected to boost the market’s growth.
Data Bridge Market Research analyses that the optogenetics market which is USD 0.31 billion in 2022, is expected to reach USD 1.11 billion by 2030, at a CAGR of 17.35% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015- 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Light Equipment Type (Laser, and Light-emitting Diode (LED)), Actuator (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin), Sensor (Calcium Aequorin, Cameleon, and Other, Chloride (Clomeleon), Membrane-gated (Mermaid), Application (Neuroscience, Behavioral Tracking, Retinal Disease Treatment, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Elliot Scientific Ltd (U.K.), Shanghai Laser & Optics Century Co. Ltd. (China), GenSight Biologics (France), Danaher (U.S.), Cohorent, Inc. (U.S.), Thorlabs, Inc. (U.S.), Prizmatix (Israel) , Bruker (U.S.), Scientifica (U.K.), Judges Scientific plc (U.K.), Addgene (U.S.), THE JACKSON LABORATORY (U.S.), Noldus Information Technology (China), Merck KGaA (Germany), agtc (U.S.), Circuit Therapeutics, Inc. (U.S.), Laserglow technologies (Canada), REGENXBIO Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Optogenetics is a scientific methodology that combines genetics and optical technologies. It is mostly used to manage and control the biological processes of neurons and other light-sensitive cells. Individual behaviour and physiology, such as locomotion, learning, memory, navigation, metabolism, respiration, and sensor processing, are better understood with this knowledge. Optogenetics contributes to clinical discoveries by illuminating the neuronal processes involved in a variety of disorders such as drug addiction, obsessive compulsion disorder (OCD), Parkinson's disease, stroke, chronic pain, epilepsy, social dysfunction, anxiety, and depression.
Drivers
According to the National Center for Chronic Disease Prevention and Health Promotion (January 2021), four out of every ten adults in the United States have two or more chronic diseases, and six out of every ten adults have one or more chronic diseases. These diseases cost the country's healthcare system USD 3.8 trillion per year, which could significantly impact the industry's development under consideration. Rising government initiatives are the primary drivers of growth in the neurological field. With more investment, more businesses can enter the market and provide innovative solutions to patient needs.
According to the Alzheimer's Impact Movement study from July 2020, more than 5 million Americans have Alzheimer's disease, and an estimated 16 million are looking for unpaid care. Alzheimer's disease will cost the country USD 305 billion in 2020, with Medicare and Medicaid payments accounting for USD 206 billion. More care is required for the growing patient population, increasing the optogenetics demand and accelerating market growth.
Partnerships and agreements are another factor driving market growth. For instance, in September 2021, NeuroLux Inc. announced an exclusive partnership with TSE Systems to integrate its wireless technology with TSE Systems' IntelliCage and PhenoMaster platforms, providing optogenetic, pharmacology, telemetry, and other capabilities for cutting-edge behavioural neuroscience research.
Opportunities
The increase in government efforts in the neurological field is one of the primary drivers of market growth. As funding grows, more competitors will be able to enter the market and offer cutting-edge solutions to meet the needs of patients. According to the National Center for Chronic Disease Prevention and Health Promotion (January 2021), six out of every ten adults in the United States have a chronic disease, and four out of every ten adults have two or more chronic diseases. These conditions impose an annual burden of USD 3.8 trillion on the nation's healthcare system, which is expected to significantly impact the market's development.
Restraints/Challenges
LEDs are generally limited to several hundred megabits per second links, whereas lasers can be 25-50 gigabits per second links when directly modulated. As a result, the low efficiency of optical fibres limits the use of LEDs in some applications.
However, the lack of awareness of optogenetics in developing economies compared to developed economies will pose a challenge to the growth of the optogenetics market.
This optogenetics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the optogenetics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The global COVID-19 pandemic is expected to significantly impact the optogenetics market. SARS-CoV-2 has an 85% prevalence in Alzheimer's patients, according to Shanet Suzan Alex's paper for PUS University in February 2022, and causes cerebral problems in addition to respiratory symptoms. Furthermore, SARS-CoV-2 infiltrated the cognitive centres of COVID-19 patients, resulting in Alzheimer's-like phenotypes in people with no other underlying illnesses and worsening Alzheimer's neuropathology in people who already had Alzheimer's and autism, according to the same source. The COVID-19, which has been linked to neurological illnesses, has increased death rates and had a significant impact on the market.
Recent Development
The optogenetics market is segmented on the basis of light equipment type, actuator, sensor and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Light Equipment Type
Actuator
Sensor
Application
The optogenetics market is analyzed and market size insights and trends are provided by country, light equipment type, actuator, sensor and application as referenced above.
The countries covered in the optogenetics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the optogenetics market due to the development in the application of optogenetic tools, principally in educational and analysis labs.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the growing healthcare sector researches across the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The optogenetics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for optogenetics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the optogenetics market. The data is available for historic period 2011-2021.
The optogenetics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to optogenetics market.
Some of the major players operating in the optogenetics market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.